Lipopolysaccharide-induced interleukin-6 production is controlled by glycogen synthase kinase-3 and STAT3 in the brain.

Lipopolysaccharide-induced interleukin-6 production is controlled by glycogen synthase kinase-3 and STAT3 in the brain.
复制标题

脑内脂多糖诱导的白介素-6的产生是由糖原合成酶激酶3和STAT3控制的。

DOI:
10.1186/1742-2094-6-9
复制
发表时间:
2009-03-11
影响因子:
9.3
通讯作者:
Jope RS
Jope RS
中科院分区:
医学1区
文献类型:
--
作者:
Beurel E;Jope RS

文献摘要

参考文献

被引文献

相似文献

感染性休克是一种普遍的疾病,当不致命时,通常会导致认知、情绪和行为障碍,特别是由于炎性细胞因子白细胞介素-6(IL-6)的中枢作用。为了确定控制脑IL-6的潜在靶点,我们测试了神经胶质细胞产生的IL-6是否受信号转导和转录激活因子-3(STAT 3)和糖原合成酶激酶-3(GSK 3)的调节。用脂多糖(LPS)诱导小鼠或培养的原代胶质细胞的炎症反应。通过ELISA测量IL-6,并使用阵列测量其他炎性分子。小鼠脑IL-6水平增加后,中央,以及周边,LPS管理,与神经胶质细胞产生一部分的脑IL-6。在外周或中枢给予LPS后,以及在LPS刺激的培养的原代胶质细胞中,脑中的STAT 3被激活。抑制STAT 3的表达、功能或活化可使原代神经胶质细胞的IL-6产生减少约80%,表明对活性STAT 3的依赖性。GSK 3促进STAT 3活化,并且对由LPS刺激的原代神经胶质细胞产生的炎性分子的阵列分析表明,IL-6是通过GSK 3抑制而减少最多(>90%)的细胞因子。抑制GSK 3和敲低GSK 3 β(而非GSK 3 α)可显著抑制LPS刺激的原代胶质细胞产生IL-6。相反,活性STAT 3和活性GSK 3的表达促进IL-6的产生。体内抑制GSK 3降低了LPS给药后血清和脑IL-6水平、脑STAT 3活化和GFAP上调。STAT 3和GSK 3协同促进神经炎症,为抗炎干预提供了新的靶点。
Septic shock is a prevalent condition that, when not lethal, often causes disturbances in cognition, mood, and behavior, particularly due to central actions of the inflammatory cytokine interleukin-6 (IL-6). To identify potential targets to control brain IL-6, we tested if IL-6 produced by glia is regulated by signal transducer and activator of transcription-3 (STAT3) and glycogen synthase kinase-3 (GSK3). Lipopolysaccharide (LPS) was used to induce inflammatory responses in mice or cultured primary glia. IL-6 was measured by ELISA and other inflammatory molecules were measured using an array. Mouse brain IL-6 levels increased after central, as well as peripheral, LPS administration, consistent with glia producing a portion of brain IL-6. STAT3 in the brain was activated after peripheral or central LPS administration, and in LPS-stimulated cultured primary glia. Inhibition of STAT3 expression, function, or activation reduced by ~80% IL-6 production by primary glia, demonstrating the dependence on active STAT3. GSK3 promotes STAT3 activation, and array analysis of inflammatory molecules produced by LPS-stimulated primary glia demonstrated that IL-6 was the cytokine most diminished (>90%) by GSK3 inhibition. Inhibition of GSK3, and knockdown of GSK3β, not GSK3α, greatly inhibited IL-6 production by LPS-stimulated primary glia. Conversely, expression of active STAT3 and active GSK3 promoted IL-6 production. In vivo inhibition of GSK3 reduced serum and brain IL-6 levels, brain STAT3 activation, and GFAP upregulation following LPS administration. STAT3 and GSK3 cooperatively promote neuroinflammation, providing novel targets for anti-inflammatory intervention.
DOI: 10.1083/jcb.85.3.890
发表时间: 1980-06
期刊: The Journal of cell biology
影响因子: --
作者:
McCarthy KD;de Vellis J
通讯作者: de Vellis J
DOI: 10.1084/jem.20030077
发表时间: 2003-11-17
期刊: The Journal of experimental medicine
影响因子: --
作者:
Kano A;Wolfgang MJ;Gao Q;Jacoby J;Chai GX;Hansen W;Iwamoto Y;Pober JS;Flavell RA;Fu XY
通讯作者: Fu XY
DOI: 10.1126/science.278.5337.477
发表时间: 1997-10-17
期刊: SCIENCE
影响因子: 56.9
作者:
Bonni, A;Sun, Y;Greenberg, ME
通讯作者: Greenberg, ME
DOI: 10.1074/jbc.m802481200
发表时间: 2008-08-08
影响因子: 4.8
作者:
Beurel, Eleonore;Jope, Richard S.
通讯作者: Jope, Richard S.
DOI: 10.1186/cc5783
发表时间: 2007
期刊: Critical care (London, England)
影响因子: --
作者:
Bozza FA;Salluh JI;Japiassu AM;Soares M;Assis EF;Gomes RN;Bozza MT;Castro-Faria-Neto HC;Bozza PT
通讯作者: Bozza PT